510(k) K896111
K896111 is an FDA 510(k) premarket notification submitted by Fresenius USA, Inc. for the device "FRESENIUS BIOCARB HEMODIALYSIS GRADE SODIUM BICARB". The FDA issued a decision of Substantially Equivalent on December 27, 1989. The device falls under product code KPO (Dialysate Concentrate For Hemodialysis (Liquid Or Powder)), a Class II device regulated under 21 CFR 876.5820. Fresenius USA, Inc. has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- December 27, 1989
- Date Received
- October 23, 1989
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Dialysate Concentrate For Hemodialysis (Liquid Or Powder)
- Device Class
- Class II
- Regulation Number
- 876.5820
- Review Panel
- GU
- Submission Type